<SEC-DOCUMENT>0001615774-18-001868.txt : 20180314
<SEC-HEADER>0001615774-18-001868.hdr.sgml : 20180314
<ACCEPTANCE-DATETIME>20180314061356
ACCESSION NUMBER:		0001615774-18-001868
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20180314
FILED AS OF DATE:		20180314
DATE AS OF CHANGE:		20180314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Immuron Ltd
		CENTRAL INDEX KEY:			0001660046
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C3
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38104
		FILM NUMBER:		18688277

	BUSINESS ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
		BUSINESS PHONE:		61 03 9824 5254

	MAIL ADDRESS:	
		STREET 1:		62 LYGON STREET
		STREET 2:		LEVEL 3
		CITY:			CARLTON, VICTORIA
		STATE:			C3
		ZIP:			3053
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>s109353_6k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Form 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 UNDER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">For the Month of March 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Commission File Number: 001-38104</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>IMMURON LIMITED</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Name of Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>Level 3, 62 Lygon Street, Carlton South,
Victoria, 3053, Australia 3053 </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Form 20-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT>
Form 40-F <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Yes <FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9744;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
<FONT STYLE="font-family: Segoe UI Symbol,sans-serif">&#9746;</FONT></P>

<P STYLE="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If &ldquo;Yes&rdquo; is marked, indicate below the file number assigned
to the registrant in connection with Rule 12g3-2(b): 82-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>IMMURON LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B><U>EXPLANATORY NOTE</U></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immuron Limited (the &ldquo;Company&rdquo;)
published an announcement (the &ldquo;Public Notice&rdquo;) to the Australian Securities Exchange on March 14, 2018 titled &ldquo;Immuron
Announces A$5.1M Private Placement to U.S. Fund&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A copy of the Public Notice is attached as
an exhibit to this report on Form 6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This report on Form 6-K (including the exhibit
hereto) shall not be deemed to be &ldquo;filed&rdquo; for purposes of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such filing.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBITS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; border-bottom: black 1pt solid; padding-right: 5.4pt"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>Number</B></FONT></TD>
    <TD STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 92%; border-bottom: black 1pt solid; padding-right: 5.4pt"><BR>
<FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="s109353_ex99-1.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; text-align: justify"><FONT STYLE="font-size: 10pt"><A HREF="s109353_ex99-1.htm">Immuron Announces A$5.1M Private Placement to U.S. Fund</A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>IMMURON LIMITED</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 56px; width: 144px"></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 52%"><FONT STYLE="font-size: 10pt">Date:&nbsp;&nbsp;March 14, 2018</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 46%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ Peter Vaughan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Peter Vaughan</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Joint Chief Financial Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>s109353_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.gif" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Immuron
Announces A $5.1M Private Placement to U.S. Fund</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.35pt"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/130% Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt/130% Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Melbourne, Australia, March 14, 2018:</B>
Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian microbiome biopharmaceutical company focused on developing and commercializing
orally delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases, is pleased
to announce today that it has finalized a private placement capital raising with a large U.S. institutional investment fund.</P>

<P STYLE="font: 10pt/130% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Joseph Gunnar &amp; Co., LLC and H.C. Wainwright
&amp; Co. acted as exclusive joint placement agents for the offering.</P>

<P STYLE="font: 10pt/130% Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt/130% Times New Roman, Times, Serif; margin: 0; text-align: justify">The terms of the private placement will
raise Immuron approximately A$5.1 million (before costs of the offer) for the issuance of 13,162,744 new ASX shares at A$0.39 per
share, plus three new free-attaching options for every 5 new shares issued resulting in 7,897,647 new options being issued exercisable
at A$0.468 per option, expiring 5 years from the date of issue. The placement is expected to complete on March 15, 2018, subject
to customary conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immuron expects this capital raise to secure
the future funding needs of Immuron&rsquo;s other ongoing clinical programs, support marketing initiatives surrounding the Company&rsquo;s
flagship product Travelan, which has already experienced significant sales growth through the first half of financial year 2018,
and provide ongoing working capital for the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Immuron&rsquo;s CEO Dr. Jerry Kanellos commented:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 16.65pt 0 14.2pt; text-align: justify"><I>&ldquo;Immuron has received
a number of recent offers for financial support following the release of the Company&rsquo;s positive top-line results of its IMM-124E
Phase II Non-Alcoholic Steatohepatitis (NASH) clinical study.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 16.65pt 0 14.2pt; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0; margin-right: 16.65pt; margin-left: 14.2pt"><I>We&rsquo;re
very pleased that we have been able to partner with this large US institutional investor for this raising and for them to take
such a significant position in our Company brings stability and validation to the Company&rsquo;s share register.&rdquo;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>This press release and the information
it contains does not, and will not, constitute a public offering to subscribe for or sell, nor the solicitation of an offer to
subscribe for or buy, securities of Immuron in the United States or any other jurisdiction where restrictions may apply. Securities
may not be offered or sold in the United States absent registration or an exemption from registration under the US Securities Act
of 1933, as amended and applicable State securities laws. Immuron does not intend to register securities or conduct a public offering
in the United States.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><I>This distribution of this press release
may be subject to legal or regulatory restrictions in certain jurisdictions. Any person who comes into possession of this press
release must inform him or herself of and comply with any such restrictions.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">- - - END - - -</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="color: #0079C1; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B><U>COMPANY CONTACT:</U></B></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>&nbsp;</B></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>Jerry Kanellos</B></P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Chief Executive Officer (Interim)</P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Ph: +61 (0)3 9824 5254</P>
        <P STYLE="color: #231F20; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">jerrykanellos@immuron.com&#9;</P></TD>
    <TD STYLE="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><B><U>USA INVESTOR RELATIONS:</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><B>Jon Cunningham</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20">RedChip Companies, Inc.</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20">US Ph: +1 (407) 644 4256,
        (ext. 107)</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20">jon@redchip.com</P></TD>
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><B><U>AUS INVESTOR RELATIONS:</U></B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #0079C1"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20"><B>Peter Taylor</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20">NWR Communications</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #231F20">Ph: +61 (0)4 1203 6231</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">peter@nwrcommunications.com.au</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img003_v1.jpg" ALT="(Immuron Logo)">&nbsp;</FONT></P>
<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img004_v1.jpg" ALT="(immuron logo)">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B><U>ABOUT IMMURON:</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white">Immuron Limited
(ASX: IMC, NASDAQ: IMRN), is an Australian microbiome biopharmaceutical company focused on developing and commercializing orally
delivered targeted polyclonal antibodies for the treatment of inflammatory mediated and infectious diseases.. Immuron has a unique
and safe technology platform that enables a shorter development therapeutic cycle. The Company currently markets and sells Travelan&reg;
for the prevention of Travelers&rsquo; Diarrhea and its lead clinical candidate, IMM-124E, is in Phase II clinical trials for
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-Alcoholic Steatohepatitis</B> (NASH), <B>Severe
Alcoholic Hepatitis</B> (SAH) and Pediatric <B>Nonalcoholic Fatty Liver Disease</B> (NAFLD). Immuron&rsquo;s second clinical stage
asset, IMM-529, is targeting <B>Clostridium <I>difficile</I> Infections</B> (CDI). These products together with the Company&rsquo;s
other preclinical immunotherapy pipeline products targeting immune-related diseases currently under development, will meet a large
unmet need in the global immunotherapy market</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white">For more information
visit: http://www.immuron.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>FORWARD-LOOKING STATEMENTS:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify"><B>This press release may contain &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A
of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Such statements include,
but are not limited to, any statements relating to our growth strategy and product development programs and any other statements
that are not historical facts. Forward-looking statements are based on management&rsquo;s current expectations and are subject
to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock value. Factors
that could cause actual results to differ materially from those currently anticipated include: risks relating to our growth strategy;
our ability to obtain, perform under and maintain financing and strategic agreements and relationships; risks relating to the results
of research and development activities; risks relating to the timing of starting and completing clinical trials; uncertainties
relating to preclinical and clinical testing; our dependence on third-party suppliers; our ability to attract, integrate and retain
key personnel; the early stage of products under development; our need for substantial additional funds; government regulation;
patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim
any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to
reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based,
except as required by law.&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: justify"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="color: black">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="img003_v1.jpg" ALT="(Immuron Logo)"></FONT></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !& +0# 2(  A$! Q$!_\0
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M5UN4$#?' 88?KYDF!CZ9H%AX]UX WNI67AVV/6&P7[1.1Z&1OE!^@-=N
M  .@I: .<T/P3I&A737L4<MUJ3C#W]Y(99F]?F/W1[#%='110 4444 %>>ZK
M?:GXV\0W7AS1;R6RTFP<)JFHPMB1WQGR(CV/]YNU>A5YCH^JQ_#74=4TOQ%O
MATZ]OI;VRU18B82)#DQR$#Y6!SUX(H [FSL]'\*:&L$"06&G6R9)9MJCU+$]
M2?4\FN;?Q'K7BIC#X3C6ST[H^LWL)VD?],8SC?\ [QX^M<+<^)KKQKXOOULU
ML;ZRL)_+M!>7:)81\#$[KG=,YYP!P..]:FN:-I6IVB#Q)\4B%1LRPV<\4$.
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(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#EA# %* /<  /______S/__F?__9O__,___ /_,___,S/_,F?_,9O_,
M,__, /^9__^9S/^9F?^99O^9,_^9 /]F__]FS/]FF?]F9O]F,_]F /\S__\S
MS/\SF?\S9O\S,_\S /\ __\ S/\ F?\ 9O\ ,_\  ,S__\S_S,S_F<S_9LS_
M,\S_ ,S,_\S,S,S,F<S,9LS,,\S, ,R9_\R9S,R9F<R99LR9,\R9 ,QF_\QF
MS,QFF<QF9LQF,\QF ,PS_\PSS,PSF<PS9LPS,\PS ,P _\P S,P F<P 9LP
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M,S.9 #-F_S-FS#-FF3-F9C-F,S-F #,S_S,SS#,SF3,S9C,S,S,S #, _S,
MS#, F3, 9C, ,S,   #__P#_S #_F0#_9@#_,P#_  #,_P#,S #,F0#,9@#,
M,P#,  "9_P"9S "9F0"99@"9,P"9  !F_P!FS !FF0!F9@!F,P!F   S_P S
MS  SF0 S9@ S,P S    _P  S   F0  9@  ,P
M
M
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E$INX<(D8BJ(XBJ18BJ9XBJB8BJJXBJS8BJ[XBK 8BY$7$   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img003_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img003_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 5P-( P$1  (1 0,1 ?_$ .,  0  !@,! 0
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MJ("OXN \B]* B B B B B B B B B B B B B B B B B B B B B B B B
MB B B B B B B B B B B B B B B B B B B B B B B B B B B B B B
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MQZ2I.96A6Q+&6*M36.)L,'\2^5/"'[PEI5V)OYHE%<$DNO-]G0=W/RQTDSD
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M)\BIU,ERG:&7AH2J>(I5QWFJJ.$;@ J:JJSJM2EGYK4I1_69F**ZIZ% DD7
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M]1:^\%2I4011J?GQX@J* (@(@*JC4_,P5% %5 1 1 1 1 1 1 1 1 1 1 1
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MQ.ZRH@J("H@(@(@(@*J BC4_,P5% %5 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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7 B B B B B B B B B B B B B B_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img004_v1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img004_v1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ,@"W P$1  (1 0,1 ?_$ ,    (#  ,! 0
M       )!P@* P4& @0!  (# 0$! 0             (! 8'!0(! Q    8"
M 0," P0##0D      0(#! 4&!P@ $1()(1,Q%!5!(A8*46$7<8&1H3)"4B.V
M-W<9.;+#)'6U=E>GMQ$  @$# P(#! (-!PH'     0(#$00% !(&(0<Q01-1
M(A0(83)Q@9&Q4F)R<[-TM!460I*R(S4W.,'",T/#-(0E-B>A@F,D9748_]H
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M"22F^.)Y$(/UO2DV&G7<*,M214J6V$_U\<*_XBXQ_P!MUS8N.?X>+[]6N/\
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M '0H>@<;WO6[7':C"W,I+2F6U))\26M)"3]L^.E%[*HL'=;-6\0VQ+%=  >
M"W<8 ^UY:^/)&P963S:ZKP<N@F]BUI/5^/=,UP!1%PT6R:_<+MU"&[BBDL#D
MP&*(=! 1Z_'GWMD[VW8K+W$)VS!+X@CQ!$*BNCN6B77?+$V\P#1%K$$'P(,S
M$C6LSB@Z;K60OQ54R%@O,7L3!M63<&=$6V8;5Y/V4REC"L<CM*VV,T* =$#)
M0[Y5N';T_JE#!\!XY'=J^GN.R^-G=CON!9%_QJPE^OM]X _9ZZ3KM-8P6_>?
M)6ZJ-MN;T)^+28)T]GNDC['36DW>.,93&FNTT?(-47C57 655#(+D*H3WFE,
MF';58"F] 5;.D"*IF^)%" 8/4 XL? Y9(>:XF2,E7&0@ZCZ9%!^Z"0?HTS7.
MHHYN%Y6.4!D./GZ'Z(V(^X0"/ITF[\N,Y4-@_8QD*AQ0;Y5K3I-(3#V$5=U0
MR*RA2_ #JD8I@8?B($#]'-K^9A%&>QC@>\;.0?<E-/OZQ7Y:G8X+)H3[HNXS
M]V+K][4">*H0+YAMU2F]#".R0  _$1#.]?$0#]X.=_NT/^S&"/E_[/\ 97UP
M>T_]\V<_XS]J76K/BDZ;/63Y^ F_,<-^T?A<F(B(=!]"ZOI=P?OAZ?JXW4?^
M&D_F3^W:4F3_ !*+^='[%K\?YA:(4L&R6K$"D?VU9J@OXI(_3N[%)"]&:$-V
M_P [M,J ].?M\N,PM^+Y>X/41W*M_-A)_P FOP^8R$W')\3;CQDMF7^=,!_E
MUHSRM"J80TYR? XD8A$.L4ZW7ECCEC&I%3,R?TW&DJ2L$:IH%+U<$>1Z(@(!
MW'4]?B/7BNV]TV9Y-'=Y1M[75\K2D^?J2@O7Z.I^UIM,78VV-M+?&VRA+2!$
MC4#P"J H_P# :2)X<ZK :0^%V V&HE2)>\X[!#(7Q9LBD=Q,Y#RG=;\\QAAJ
ME.'9!,_7BXY=9@DHD!^B2CA\L7M,JH8=4YLK\P[J?N&^F^'PUH=C,?JQ011^
MM/)3PKM#$=.M$'D-1.<9R?!XFYR%M$9[R-52"(>,DTC+'$G_ )I'6OXM?9J'
MYSPG[W;)W8,P;+[(T./NUC?IR,N'U&T7*:K+8RY5TXJ*:LHN(K3)*)+]U!E'
MO2L41*!4E.WH;FE6_?;M]Q>Q_<O%<7<M81*57I'$DG2FYZEI&W>+,XW'S'EI
M69^Q?<#E%]^^>4Y2V6_E8,W625HQ6NU*!47;X*J':*"A\]-,S]&8U@/(9XR8
MR%L#*8V$8P.P% MK0'#9S:9_6S]ADY)SLK?VS<YW)8-'*D#7UXTSPH(GDG;D
M&_4QE^8%C9KV?BN;F="F(:2"1*5"+<>N JQGPKZ32 TZ[0*^6F\M(6AQ_P ,
MY+QHB+N;Q8B@J?I(J3J<L(9:FHJW;DZ[2<FO(R>M<A%V/'TL[74<R'[+<J45
M:\4F&>KK&47=+T:7;2,0BJH<RBD>U:=XF.!S&]9W$02V>%Y)$H6+)JR3*!0>
MO!*(I6 '0"52DA Z!V>G2@UGN"R\\5YFN.2N6EQC*\+$U/H3Q&6)2?$F)@\8
M)ZE%2O6ITD#\NI48FR9+VBRU-MTY*XQ$)28*-EW:9%W;1"[2MGEK*JBNH!E"
M.)1>LM 4. @82$,'7H<P#NWS)WLUMB\3AX25LG>1V4>!,2HB"GL4.U/L_1K"
M_EOLH+G*9;+S@->HD:!CU($K2,Y!]K%!4_1K5<[:-7[5RQ?-D'C)XW6:/&CI
M%-PU=-7"9D7#9R@J4Z2Z"Z1Q*<A@$IBB(" @/%*1WC<21DJZD$$&A!'@0?(C
MR.FR=$D0QR ,C @@]00>A!'F#YZRH^*BG5]IL=Y5M9TV!0QA-U3)51=P8"()
M&@*U=[S0H]@(@;U!.O6]TB ]>O0PCQMN[=_<OQGB7*"W_-8YH9 _GO>**5C_
M #XU.E,[36-NG)N6\7"_\K>&:,K^(DLL0'\R1AKI]@>G^?EA;K_Y#QI_#U>=
M/X^2>.?X>+[]6G^^FHW(O\0MC^LP?Y^IQ_,@B'X#U5#KZ_C#)X]/MZ?2J2'7
MG ^63^T<N?\ T;?^G)KO?,S_ &=B?ST_]"/6@/ 8 &"L+  = #$N.0  ^ !^
M#H;T#BZ<@_M^^_7)OTC:8GC_ /8-E^J0_HUUF,W<,7_/EU[]0]+KK&4?U&&0
MBN@?O]P?P\:C@H/_ .?,E^8OOO:5KG)'_P"@,=^?L?OC6LWB@:;S63?Q _ZL
MVXW_ "38C_[[3^-WWD_N@PGYRT_9)-*-V;_O>S?YN[_:X]?H\@Q>WSF:J#_3
MG]7#_P#L5PG_ +OAVZ->PF7^B.^_0C7KN&*=^<3],EC^E;6L#BB:;?63_P 9
M!B_YTNX/7XF>[0=H]/M#,T,(A^H>@#QNNZ7]R&%_)L?V=M*1VN/_ 'OS7Y5]
M^TKK11N@;MU"VA-\>FO^7?[!SO%MX3UYCBA_\C;_ *5-,AS7_H[*_P#U]Q^B
M;25ORXG]SFRG^)=/_LU(\W/YF?[:Q?ZK+^D&L.^6G^Q<I^M1?HSJFC/(B/C2
M\SF5+=ER/D66,<I6"[NW=@2:K. 3H.9Y4ELB[9'H(D55DFM>LK=-!Z1(#*@#
M-V1,IE2E*-T?&'NAV1L[/#,K96TCB 0D#^NMEV-&?87C-4)H"67K0UU2DR:]
ML.]EY>9E67%7<DI+T)I#<L)%D 'U@CBC@5(VM3J*:TXV/<_5"K8Y5RQ+;"8E
M_ A(PLHWF(^[P,LK)(J)%40:Q$5&/74O*RKCN A&;=!1T90>WV^X! %9MN$<
MNN\F,/#C;S]X;MI4Q.M#[68@*JC\(D+3K732W/-N)6F-.7FR-G^[PN[<)4:H
M]BJI+,Q_! +5Z4UFS\?4G-[Q^8?(&V\% R,7CVGNK;=55W9"_P# 1+JG.L68
MZB)%5,QD"3TO'JD='1(8Q>K1R)!,5/J+.=QH;?@79>VX?/(KY*<1Q=/Y3"03
MSLOGL4^Z#^,OMTLO;J:?GG>:YYA;QLF-A,DA)\E,?H0*WEO8>\1^*WLU(/GA
M$"[B:6&'X!"LA']P,FMQ'D#Y?O\ HK._EG]G;4_O]_UK@_R!^T+K5 X;H.T%
MFKI%)PV<HJ-W#==,JJ*Z"Q#)JHK)' Q%$E4S"4Q1 0$!Z#Q2@2I#*:,--GI-
ML3K=E33/6C)&%<>5QSD/%^O66V>T6JQ6"I'$D;&L1E5IEZYZY6)B?N?)VBI"
MZFVM<>IE50E(UTR+_5NFJZ9M4Q^9QO(^2P7N1D%O<Y"V:SNF/@LDD)@CN0?#
M8Q]-I1T*D/XJP.JUSKXI\"^2L(S+?6<D-R(QXR?#R+(ZK[6>-6"CQWTTIOS#
MUGR=;]6?7[*/C"R+D*]ZCV['#".>P6$LLL\8R-;RN,]-*V4V767XMJC_ -Y*
M$>1R!2.U5D8Y1JX(9-$Q^]Q=>#Q\1X/\;B>?V\4')89R:SQ&4-%0;?1.U@02
M&-0/>!!!/@+!Q;D. Y!B8\OC94FM914-XD=!56'4JZGHRFA!U:#Q>>.:N>(G
M'N4MW-_<PPD[L7=JR6!F9QY/N[0A0:FHNUE%:)6YR5,:7OF0KC*QS4'9VI3E
M-\HDV:]Z8+.%^)RWDM]W-R5MQ+A=J_[L22JJ%";V\/4<+[L<: FF[PJ6;K0#
M\^3\GQ."QKY+*RI;XV$5);H6/DJKXLQ\%45).K+^.&3N6>&V^6]MN@GU9AME
M);Z%C*(D1#WR8YQ+6+#!Q+CJ43)+D13D",E5D^B:KYDZ$H=.G)7<Z&RX\_'^
MW]G(LMQBX]T[+X>O<2([#Z/#< >H5EKUUB/;*:^Y"G(.?WD;16^4?; K>(AM
MXW13[//:2.A96IJGWY;H2^QMJ =.X5L/B'Z>WID?^+J/+E\S/CAOR;C_ &.J
M=\M!Z9D?C6_^VUJ&XJFFHUE[\6/^H7Y0_0/Y68_7[?[Z)CT_<'C5=V/[M^*?
M\/\ LRZ5GM3_ 'D<J_XC]I;3?+EXVL%W?;VJ;FRL[D-')%2DH699P#.8AR4Y
MW)P!7/TYPZ:JP"TR"95%BF.DF](0XI@'3H8P#CEEW/Y!8<+FX/#';'%S*RER
MC>J%>FX [POET)4^.M@O>V. O^9P\WEDN1E(65@@=?3+)7:2-I;SZ@, ::])
MNSH+B3>V+Q[$96L%Y@&^-Y.>E(<](?PK%9VI86\6V>HR S4%.)G2(6)2%/VR
MIF*/=U$0'IR-P3N)F>WTUS/AX[>1KI$5O55F V$D$;67K[QK6NI/.NWF&[@0
MVT&8DN(TMG=E])E4G> "#N5O8*4IJXU5KD=3ZQ7*C$?,?2:M P]<B_FU??=?
M3H2/;QC+YE<")@LX^6:E[S]I>XW4>@<I-W<R7MU+>34]:61G:G058EC0>0J>
MFKK:6T=G:Q6<-?1BC5%KU-% 45/F:#KJBF4?&S@K+6W%)W(L<WD)MD:D/Z5*
MLX*+F(A"H2,G05"*UYR_:N()U,%(0[=#WTD7B1%@1^ =Y^Z_XKN?R##\-GX1
M;1VQQDZRJ79&,BB;ZX!#!?;0E32OV-4'*]L<!F.8P<VN9+D9.!HF"*RB-C#]
M0D%2WLJ PK3[.F$\SC6C:7UKAXW<&ZQ;"90V2HD]D24N^5&UM:2\?9IB&>5Z
M,;W6W,+G-%BVL? 1CTRGU2,1(B=PX7,FB!@]3&$W-&Y-W-SW*N.6G&,A';)8
M69C*M&C!V,<9C7<2[#ZI)- *GK]&LZXSVSP/%>1W?)\?)<M?W8D#!V4HHDD$
MK;0$!^LH J30:YLU^.7"&<MH\8;;6.<O\1DK%SRDO(YA!2L.G6)H] L![% %
MEV,A!2#\H Z4,FO\LZ0]U'H'0I@$P^<'W,SV!XG=\-MH[9\7=B4,75O47U4V
M/M8,!X"HW T/T=->LYVUP6>Y7:<QN9+E,I:&(J$9?3;TG+IN4J3XD@T(J/NZ
MO_S.]:'I?."?&[@W7W9W)NUE/G<@R.0,H*WA:3BI^7B'58B5,@V9O:K ,2U9
M03"2$/J#8"( X=+@DB(A]XW0P:-R#N;GN1\5M.(WL=LN.M!$%9%82-Z2&--Q
M+$>!J:**GZ.FL[P';/ \=Y5=\NLI+ELC=^KN5V4QKZKAVV@*#XB@JQH-72R1
M0X3*6/;QC2RB\+7<@5*Q4R</'+E;2!(FS1+N'D#L7)TUB(/"-7AA2.)#@4X
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MC5$'(L"*@V0[E 1(F4PASC\CSE]E>.87F,S!>40WEQ"UPH"R2_#_  TL$CD
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M=M:ZHD04T3#WG+UZ!U$/7!>16'&N60YS(I*]BBSAA&%+TEADC% Q"]"X)J?
M:^<YX]?<EXG-A,>T27KF$J9"P2L4L<AJ5!;J$(%!XG7FX&4\EAIN%)9:;I*C
M7!E8XM@6A+YG!Q-)0@NT0E58A!]14&2THFP]P6Y%E")&5 H',!1$>2IXNV @
M<VT^=-SL.P-%:A=U/=W$2DA:TJ0":> U%MY>YQG074&#%MO&\K+=%MM1NV@Q
M %J5I4TKXG40P.#]Y\,9HV:N.$6NJUBIN?<K(Y(:*92M&5HVR08HUB(KA&3B
M/JE1=QJJ92QGN"!7(F$1'[X=0 O:N<_P+.8/%6.<.6BO<=9F ^@ENR/61Y*@
MR2!A]:G4?:UQ;; \]P><RM[@QB9;+(W@G'KO.KI2-(Z$1QE3]6OC]O4T83UV
MS7C1CL)ENWY,I]\VOSS"QB?UD8"9B<+4IU0H"R1^)ZA"5HDBXLBE(K\I8EUI
M%85TY"1*L<QNBP <W$SW)<'E'QN&LK6:WXACW;W=ZM<R^LZ&XE=Z",2NJ (
MNQ-H'4:[>"XUG,6F2S%[=0W'+L@B^]L9;:+T4=;>)4W%S$C.6<EM[[B>AU>'
ME"U?-'#1HX:-'#1HX:-'#1HX:-'#1HX:-'#1HX:-'#1HX:-'#1HX:-'#1HX:
3-'#1HX:-'#1HX:-'#1HX:-?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
